Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US EP News Bureau Jul 16, 2025 Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
Lupin gets US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2% EP News Bureau Dec 27, 2023 It is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
